Ethketamine
Ethketamine is a dissociative research chemical structurally related to ketamine, being an N-ethyl derivative of norketamine. It is reported to produce effects similar to its parent compound, including dissociation, hallucinogenic experiences, sedation, and euphoria. It is considered potentially habit-forming. As a research chemical with very limited formal study, its safety profile, pharmacology, and toxicity remain poorly understood, presenting significant unknown risks to users.
Contents
Dosage & Duration
Dosage
Subjective Effects
Ethketamine produces a dissociative state broadly comparable to that of ketamine, though its effects remain sparsely documented. Recreational users report euphoria and a characteristic sense of dissociation from the body and surroundings. As with other arylcyclohexylamine dissociatives, hallucinogenic and sedative qualities are presumed to accompany the experience, but detailed phenomenological accounts are lacking.
Physical
The compound is presumed to carry sedative effects consistent with its similarity to ketamine, though specific reports of its body load are limited.
Cognitive
The mental state is marked by euphoria alongside a detached, dissociated quality in which awareness feels separated from the body and immediate environment.
Dissociative
Reagent Testing
Loading reagent data
Pharmacology
Pharmacodynamics
Ethketamine acts as an NMDA receptor antagonist. In mouse models, its antidepressant effects have been shown to depend on activation of both AMPA and 5-HT2 receptors, as pharmacological blockade of either receptor type abolishes this activity.
Pharmacokinetics
Tolerance
Harm Potential
Addiction & Dependence
Psychological
Categorized as habit-forming, suggesting some potential for psychological dependence, though detailed characterization of addiction potential is lacking due to limited research.
History & Culture
Ethketamine emerged as a designer drug around September 2012, when it first became available for purchase through online vendors. Since its initial appearance on the market, the compound has been identified in seized drug samples by analytical laboratories in the United Kingdom and other European countries, indicating its distribution across multiple jurisdictions within the designer drug market.
Legality
By Country
Automated synthesisInformation aggregated and synthesized using an autonomous workflow built by Josie Kins.
Suggest an edit
Spotted a mistake, an outdated claim, or something missing from the Ethketamine article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.